Skip to main content

8-K

CNO Financial Group, Inc. (CNO)

8-K 2026-05-13 For: 2026-05-12
View Original
Added on May 16, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 12, 2026

CNO Financial Group, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware 001-31792 75-3108137
(State or Other<br>Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer<br>Identification No.)

11299 Illinois Street

Carmel, Indiana  46032

(Address of Principal Executive Offices) (Zip Code)

(317) 817-6100

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, par value $0.01 per share CNO New York Stock Exchange
Rights to purchase Series F Junior Participating Preferred Stock New York Stock Exchange
5.125% Subordinated Debentures due 2060 CNOpA New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07    Submission of Matters to a Vote of Security Holders.

On May 12, 2026, the Company held its 2026 Annual Meeting of Shareholders at which the Company’s shareholders voted on the three proposals noted below, each of which is further described in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 26, 2026 (the “2026 Proxy Statement”). Voting results for each proposal are set forth below.

Proposal 1

The nine nominees to serve as directors of the Company were elected, each for a one-year term expiring at the Company’s 2027 annual meeting of shareholders and until his or her successor is duly elected and qualified. Voting results were as follows:

For Against Abstentions Broker Non-Votes
Gary C. Bhojwani 81,246,371 206,285 29,547 4,292,819
Archie M. Brown 80,925,172 526,957 30,074 4,292,819
David B. Foss 80,575,917 876,580 29,706 4,292,819
Linda T. Gibson 81,387,302 65,333 29,568 4,292,819
Adrianne B. Lee 80,925,423 511,566 45,214 4,292,819
Daniel R. Maurer 80,074,756 1,375,348 32,099 4,292,819
Chetlur S. Ragavan 81,401,173 49,310 31,720 4,292,819
Steven E. Shebik 81,406,630 45,785 29,788 4,292,819
Jessica A. Turner 80,898,124 540,596 43,483 4,292,819

Proposal 2

The proposal to approve, by non-binding advisory vote, the executive compensation of the Company’s named executive officers disclosed in the 2026 Proxy Statement was approved. Voting results were as follows:

For Against Abstentions Broker Non-Votes
79,637,913 1,675,840 168,450 4,292,819

Proposal 3

The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026 was approved. Voting results were as follows:

For Against Abstentions
83,949,859 1,766,276 58,887

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CNO Financial Group, Inc.
Date: May 13, 2026 By: /s/ Joel T. Koehneman
Joel T. Koehneman
Senior Vice President and Chief Accounting Officer

3